Press Releases

MILESTONE SCIENTIFIC TO RELEASE THIRD QUARTER 2010 FINANCIAL RESULTS ON NOVEMBER 15, 2010

-- Conference Call to Be Held on November 15, 2010 at 11 a.m. EST --

LIVINGSTON, NJ, November 3, 2010 -- Milestone Scientific Inc. (OTC BB: MLSS), the recognized leader in advanced, computer-controlled injection technologies, will release its financial results for the third quarter ended September 30, 2010 on Monday, November 15, 2010.

Joseph D’Agostino, Chief Financial Officer of Milestone Scientific will host a conference call the same day at 11:00 a.m. EST.  Those who wish to participate in the conference call may telephone 877-407-8037 from the U.S.; international callers may telephone 201-689-8037, approximately 15 minutes before the call.  A digital replay will be available by telephone approximately two hours after the call’s completion for two weeks, and may be accessed by dialing 877-660-6853 from the U.S. or 201-612-7415 for international callers, Acct# 377; Replay ID# 359568.

About Milestone Scientific Inc.
Headquartered in Livingston, New Jersey, Milestone Scientific is engaged in pioneering advanced computer-controlled injection technologies for the medical and dental markets; and currently sells its award-winning products through a global distribution network serving North America, Asia, Africa and Europe.  For more information on the STA Single Tooth Anesthesia System® unit and other innovative Milestone products, please visit the Company's web site found at www.milestonescientific.com or follow the Company on Twitter @painlessdental or become a fan on Facebook at Painless Dentistry.

Safe Harbor Statement
This press release contains forward-looking statements regarding the timing and financial impact of Milestone's ability to implement its business plan, expected revenues and future success. These statements involve a number of risks and uncertainties and are based on assumptions involving judgments with respect to future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond Milestone's control. Some of the important factors that could cause actual results to differ materially from those indicated by the forward-looking statements are general economic conditions, failure to achieve expected revenue growth, changes in our operating expenses, adverse patent rulings, FDA or legal developments, competitive pressures, changes in customer and market requirements and standards, and the risk factors detailed from time to time in Milestone's periodic filings with the Securities and Exchange Commission, including without limitation, Milestone's Annual Report for the year ended December 31, 2009. The forward looking-statements in this press release are based upon management's reasonable belief as of the date hereof.  Milestone undertakes no obligation to revise or update publicly any forward-looking statements for any reason.

Company Contact:
Joseph D’Agostino – Chief Financial Officer
973-535-2717

Investor Relations Contact:
Porter, LeVay & Rose, Inc.
Linda Decker – Vice President

212-564-4700